Please ensure Javascript is enabled for purposes of website accessibility

A New Cannabis Behemoth Was Created Last Week

By Billy Duberstein - Updated May 17, 2021 at 9:35AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The tie-up between Trulieve and Harvest Health & Wellness will be an industry juggernaut.

Last week, the rapidly evolving U.S. cannabis industry changed forever when one of the largest U.S. multi-state operators (MSOs), Trulieve Cannabis (TCNNF 2.03%), agreed to acquire a smaller but still substantial peer, Harvest Health & Recreation (HRVSF), for $2.1 billion in stock.

While most large U.S. MSOs have been scooping up smaller private companies and license holders in select states, this acquisition is the largest tie-up in U.S. cannabis history. It also occurs at a historic time, as the U.S. seems to have reached a tipping point regarding the legalization of cannabis across the country.

Given the 34% premium Trulieve is paying, Harvest's stock surged and Trulieve declined on the news. And while Trulieve does seem to be paying a healthy price for Harvest, the transaction could pay off down the road.

Cannabis plants growing towards the sky outside.

Image source: Getty Images.

The acquisition

Harvest shareholders will receive 0.117 shares of Trulieve for every share of Harvest they hold, and will end up with 26.7% of the combined company on a fully diluted basis. While Trulieve has long dominated the state of Florida, Harvest has the leading market share of 15 dispensaries in Arizona, which just commenced recreational sales in January. The combined company will also have a large-scale presence in Pennsylvania, where Harvest's nine current operational dispensaries will add to the six Pennsylvania dispensaries Trulieve just acquired since last summer. It will also add another eight dispensaries in Trulieve's home market of Florida. 

Metric

Trulieve

Harvest Health & Recreation

Combined Company

States

6

9

11

Operational dispensaries

87

39

126

Cultivation and production (square feet)

2.2 million

0.88 million

~3.1 million

2021 Revenue (est.)

$858 million

$379 million

$1.238 billion

2021 adjusted EBITDA (est.)

$379 million

$82 million

$461 million

Data source: Trulieve and Harvest acquisition presentation.

Industry-leading profitability

The resulting company will be roughly as large as Curaleaf Holdings in terms of revenue, but it will be more profitable, with combined 2021 EBITDA estimates for $461 million, good for a margin of 37% -- the highest total adjusted EBITDA and close to the highest adjusted EBITDA margins in the country.

However, consensus estimates are likely underrating the combined company's earnings power this year. Those estimates were made before each company reported strong earnings last week, with Harvest in particular beating revenue expectations by a wide margin. As the company had a number of cultivation projects come online, and with Arizona recreational sales beginning in January, more of that revenue beat flowed to the bottom line. Adjusted EBITDA margins jumped from 13.1% in the fourth quarter of 2020 to 30.3% in the first quarter of 2021. The $26.9 million in EBITDA Harvest made in the first quarter annualizes to $107.6 million, well above current analyst estimates of $82 million.

Well positioned for the future

Florida, Pennsylvania, and Arizona should be highly profitable states for the combined company, as each of those states has limited licenses, and the new Trulieve will have strong leading positions in each. Since cannabis is federally illegal and interstate commerce isn't allowed, economies of scale can only be had within the borders of an individual state.

While those three states will serve as high-profit centers, the combined company will also reach eight other states, most of which are positioned directly adjacent to these core markets -- in other words, the company will operate in 11 states across three regional "hubs" throughout the U.S.

A smiling couple in a field of cannabis.

Image source: Getty Images.

This regional hub strategy has been carefully thought out by Trulieve's management, even though the company can't yet transport cannabis across state lines.

"While we can't transport cannabis across state lines, we can share talent, we can share skillsets and we can have purchasing power for non-cannabis pieces of the supply chain," CEO Kim Rivers told Forbes magazine. "We think about it more as a distribution play." And of course, if and when the federal government decriminalizes cannabis and companies are allowed transport across state lines, the new Trulieve should have a very efficient system.

What's next

The U.S. cannabis space is rapidly evolving, but it's beginning to look more like the consumer packaged goods or alcohol industry -- only with much higher growth. If that happens, the normal competitive advantages of those industries, including distribution power, brand power, and economies of scale, will apply.

Although it paid a hefty 34% premium for Harvest, the new Trulieve looks as well positioned as any to succeed.

Billy Duberstein owns shares of Trulieve Cannabis Corp. His clients may own shares of the companies mentioned. The Motley Fool owns shares of and recommends Trulieve Cannabis Corp. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Trulieve Cannabis Stock Quote
Trulieve Cannabis
TCNNF
$13.07 (2.03%) $0.26
Harvest Health & Recreation Inc. Stock Quote
Harvest Health & Recreation Inc.
HRVSF
Curaleaf Holdings, Inc. Stock Quote
Curaleaf Holdings, Inc.
CURLF
$5.93 (3.02%) $0.17

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
394%
 
S&P 500 Returns
127%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/18/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.